The use of ancestral haplotypes in the molecular diagnosis of familial breast cancer

Genetic Testing

Volumn 11, Issue 3, 2007, Pages 208-215

  Frosk, Patrick ^a   Burgess, Susan ^a   Dyck, Tamara ^a   Jobse, Rick ^a   Spriggs, Elizabeth L ^a,b,c  

^a Diagnostic Services of Manitoba Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN MLH1; PROTEIN MSH2; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BREAST CANCER; CANCER PATIENT; CFTR GENE; DIAGNOSTIC PROCEDURE; DNA POLYMORPHISM; FAMILIAL CANCER; GENE; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NF1 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN POLYMORPHISM; SCREENING;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; GENES, BRCA1; GENES, BRCA2; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC;

EID: 35348997473     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2006.0518     Document Type: Article

References (17)

1. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405-412.
2. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
3. Bonnen PE, Wang PJ, Kimmel M, Chakraborty R, Nelson DL (2002). Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res 12:1846-1853.
4. Den Dunnen JT, Van Ommen GJ. (1999) The protein truncation test: a review. Hum Mutat 14:95-102.
5. Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L, Altshuler D, Haiman CA (2005) A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res 65:7516-7522.
6. Frueh FW, Noyer-Weidner M (2003) The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogenetics. Clin Chem Lab Med 41:452-461.
7. HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320.
8. Liu X, Barker DF (1999) Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1. Am J Hum Genet 64:1427-1439.
9. Osorio A, de la HM, Rodriguez-Lopez R, Granizo JJ, Diez O, Vega A, Duran M, Carracedo A, Baiget M, Caldes T, Benitez J. (2003) Overrepresentation of two specific haplotypes among chromosomes harbouring BRCA1 mutations. Eur J Hum Genet 11:489-492.
10. Palma M, Ristori E, Ricevuto E, Giannini G, Gulino A (2006) BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers. Crit Rev Oncol Hematol 57:1-23.
11. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187.
12. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308-311.
13. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
14. Stephens M, Scheet P (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76:449-462.
15. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117-119.
16. van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, Bodmer D, Bruggenwirth H, Mulder IM, van d, V, Elfferich P, Huisman MT, ten Berge AM, Kromosoeto J, Jansen RP, van Zon PH, Vriesman T, Arts N, Lange MB, Oosterwijk JC, Meijers-Heijboer H, Ausems MG, Hoogerbrugge N, Verhoef S, Halley DJ, Vos YJ, Hogervorst F, Ligtenberg M, Hofstra RM (2006) A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. Hum Mutat 27:654-666.
17. Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348:2339-2347.